Amgen Inc (AMGN) financials · P/E 27, rev $36.75B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Amgen Inc (AMGN) P/E 27, rev $36.75B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $36.75B | $33.42B |
| Cost of Revenue | $12.04B | $12.86B |
| Gross Profit | $24.71B | $20.57B |
| Operating Income | $9.08B | $7.26B |
| Net Income | $7.71B | $4.09B |
| EPS (Diluted) | $14.23 | $7.56 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $90.59B | $91.84B |
| Current Assets | $29.06B | $29.03B |
| Cash & Equivalents | $9.13B | $11.97B |
| Inventory | $6.22B | $7.00B |
| PP&E | $7.91B | $6.54B |
| Total Liabilities | $81.93B | $85.96B |
| Current Liabilities | $25.49B | $23.10B |
| Short-term Debt | $4.60B | $3.55B |
| Long-term Debt | $50.01B | $56.55B |
| Total Debt | $54.60B† | $60.10B† |
| Shareholders' Equity | $8.66B | $5.88B |
| Retained Earnings | -$25.11B | -$27.59B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $9.96B | $11.49B |
| CapEx | $1.86B | $1.10B |
| Investing Cash Flow | -$1.94B | -$1.05B |
| Financing Cash Flow | -$10.86B | -$9.41B |
| Dividends Paid | $5.12B | $4.83B |
| Net Change in Cash | -$2.84B | $1.03B |
| Free Cash Flow | $8.10B | $10.39B |
FAQ
What is AMGN P/E and revenue?
Amgen Inc (AMGN) P/E 27, rev $36.75B.
What is AMGN revenue?
Amgen Inc last cached revenue is $36.75B (FY2025).
Is AMGN profitable?
Amgen Inc last cached net income is $7.71B (FY2025).
What are AMGN total assets?
Amgen Inc last cached total assets are $90.59B (FY2025).
What is AMGN free cash flow?
Amgen Inc last cached free cash flow is $8.10B (FY2025).
Not investment advice. Cached statements, not a live tape.